Abstract
Cellular senescence refers to the response of cells to a variety of stimuli, many of which have the potential to induce preneoplastic or neoplastic phenotypes. These stimuli include dysfunctional telomeres, DNA damage, disrupted chromatin structures, the expression of certain oncogenes, and supraphysiologic mitogenic signals. The most prominent outcome of the senescence response is an essentially irreversible arrest of cell proliferation. In addition, senescent cells acquire marked changes in cell morphology and function. In some cases, senescent cells also acquire resistance to certain signals that induce apoptotic cell death (1–4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Campisi, J., Dimri, G. P., and Hara, E. (1996) Control of replicative senescence, in Handbook of the Biology of Aging (Schneider, E., and Rowe, J., eds.) Academic Press, New York, pp. 121–149.
Smith, J. R and Pereira-Smith, O. M. (1996) Replicative senescence: implications for in vivo aging and tumor suppression. Science 273, 63–67.
Campisi, J. (2000) Cancer, aging and cellular senescence. In Vivo 14, 183–188.
Bringold F. and Serrano, M. (2000) Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 35, 317–329.
Campisi, J. (1996) Replicative senescence: an old lives tale? Cell 84, 497–500.
Campisi, J. (1997) Aging and cancer: the double-edged sword of replicative senescence. J. Am. Geriatr. Soc. 45, 1–6.
Lundberg, A. S., Hahn, W. C, Gupta, P., and Weinberg, R. A. (2000) Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12, 705–709.
Itahana, K., Dimri, G., and Campisi, J. (2001) Regulation of cellular senescence by p53. Eur. J. Biochem. 268, 2784–2791.
Ghebranious, N. and Donehower, L. A. (1998) Mouse models in tumor suppression. Oncogene 17, 3385–3400.
Sherr, C. J. (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984–2891.
Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991) p53 mutation in human cancer. Science 253, 49–53.
Paggi, M. G., Baldi, A., Bonetto, F., and Giordano, A. (1996) Retinoblastoma protein family in cell cycle and cancer: a review. J. Cell. Biochem. 62, 418–430.
Mcleod, K. (2000) Tumor suppressor genes. Curr. Opin. Genet. Dev. 10, 81–93.
Dimri, G. P. Lee, X., Basile, G., et al. (1995) A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363–9367.
Mishima, K., Handa, J. T., Aotaki-Keen, A., Lutty, G. A., Morse, L. S., and Hjelmeland, L. M. (1999) Senescence-associated beta-galactosidase histochemistry for the primate eye. Invest. Ophthalmol. Vis. Sci. 40, 1590–1593.
Pendergrass, W. R., Lane, M. A., Bodkin, N. L., et al. (1999) Cellular proliferation potential during aging and caloric restriction in rhesus monkeys (Macaca mulatta). J. Cell. Physiol. 180, 123–130.
Paradis, V., Youssef, N., Dargere, D., Ba, N., Bonvoust, F., and Bedossa, P. (2001) Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum. Pathol. 32, 327–332.
Hayflick, L. and Moorhead, P. S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621.
Hayflick, L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614–636.
Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W., and Harley, C. B. (1992) Telomere end-replication problem and cell aging. J. Mol. Biol. 225, 951–960.
Wright, W. E. and Shay, J. W. (1996) Mechanism of escaping senescence in human diploid cells, in Modern Cell Biology Series—Cellular Aging and Cell Death (Holbrook, N. J., Martin, G. R., and Lockshin, R. A., eds.). Wiley & Sons, Inc., New York, pp. 153–167.
Campisi, J. (1997) The biology of replicative senescence. Eur. J. Cancer 33, 703–709.
Chiu, C. P. and Harley, C. B. (1997) Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc. Soc. Exp. Biol. Med. 214, 99–106.
Bodnar, A. G., Ouellette, M., Frolkis, M., et al. (1998) Extension of life span by introduction of telomerase into normal human cells. Science 279, 349–352.
Ouelette, M. M., Liao, M., Herbert, B. S., et al. (2000) Subsenescent telomere lengths in fibrob-lasts immortalized by limiting amounts of telomerase. J. Biol. Chem. 275, 10072–10076.
Blackburn, E. H. (2000) Telomere states and cell fates. Nature 408, 53–56.
Chin, L., Artandi, S. E., Shen, Q., et al. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538.
Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. A. (1996) Role of the INK4A locus in tumor suppression and cell mortality. Cell 85, 27–37.
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602.
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., and Funk, W. D. (1999) Microarray analysis of replicative senescence. Curr. Biol. 9, 939–945.
Rohme, D. (1981) Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc. Natl. Acad. Sci. USA 78, 5009–5013.
Kakuo, S., Asaoka, K., and Ide, T. (1999) Human is a unique species among primates in terms of telomere length. Biochem. Biophys. Res. Commun. 263, 308–314.
Sherr, C. J. and DePinho, R. A. (2000) Cellular senescence: mitotic clock or culture shock? Cell 102, 407–410.
Wright, W. E. and Shay, J. W. (2000) Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat. Med. 6, 849–851.
Campisi, J. E. G.-P. (2001) From cells to organisms: can we learn about aging from cells in culture? Exp. Gerontol. 36, 607–618.
Stanulis-Praeger, B. (1987) Cellular senescence revisited: a review. Mech. Aging Dev. 38, 1–48.
Freshney, R. I. (1987) Animal Cell Culture: A Practical Approach, IRL Press, Oxford, UK.
Cristofalo, V. J. and Pignolo, R. J. (1993) Replicative senescence of human fibroblast-like cells in culture. Physiol. Rev. 73, 617–638.
Balin, A. K., Fisher, A. J., and Carter, D. M. (1984) Oxygen modulates growth of human cells at physiological partial pressures. J. Exp. Med. 160, 152–166.
Chen, Q., Fischer, A., Reagan, J. D., Yan, L. J., and Ames, B. N. (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl Acad. Sci. USA 92, 4337–4341.
Shay, J. W., Pereira-Smith, O. M., and Wright, W. E. (1991) A role for both Rb and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33–39.
Band, V. (1995) Preneoplastic transformation of human mammary epithelial cells. Semin. Cancer Biol. 6, 185–192.
Bond, J. A., Wyllie, F. S., and Wynford-Thomas, D. (1994) Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9, 1885–1889.
Hara, E., Tsuri, H., Shinozaki, S., and Oda, K. (1991) Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of lifespan in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179, 528–534.
Klingelhutz, A., Foster, S. A., and McDougall, J. K. (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79–83.
Whikehart, D. R., Register, S. J., Chang, Q., and Montgomery, B. (2000) Relationship of telomeres and p53 in aging bovine corneal endothelial cell cultures. Invest. Ophthalmol. Vis. Sci. 41, 1070–1075.
Harley, C. B., Futcher, A. B., and Greider, C. W. (1990) Telomeres shorten during aging of human fibroblasts. Nature 345, 458–460.
Allsopp, R. C., Vaziri, H., Patterson, C., et al. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10114–10118.
Goldstein, S. (1990) Replicative senescence: the human fibroblast comes of age. Science 249, 1129–1133.
Dulic, V., Beney, G. E., Frebourg, G., Drullinger, L. F., and Stein, G. H. (2000) Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol. Cell. Biol. 20, 6741–6754.
Campisi, J. (1999) Replicative senescence and immortalization, in The Molecular Basis of Cell Cycle and Growth Control (Stein, G., Baserga, R., Giordano, A., and Denhardt, D., eds.). Wiley-Liss, New York, pp. 348–373.
Vaziri, H. and Benchimol, S. (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279–282.
Yang, J., Chang, E., Cherry, A. M., et al. (1999) Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274, 26141–26148.
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84–88.
Ramirez, R. D., Morales, C. P., Herbert, B. S., et al. (2001) Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15, 398–403.
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., and Tlsty, T. D. (2001) Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409, 633–637.
Campisi, J. (1999) Cellular aging/Replicative senescence, in Studies of Aging: Springer Lab Manual (Sternberg, H., and Timiras, P. S., eds.). Springer-Verlag, Berlin, pp. 35–45.
Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A., and van Lohuizen, M. (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164–168.
Jacobs, J. J., Keblusek, P., Robanus-Maandag, E., et al. (2000) Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19/ARF) and is amplified in a subset of human breast cancers. Nat. Genet. 26, 291–299.
McConnell, B. B., Starborg, M., Brookes, S., and Peters, G. (1998) Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8, 351–354.
Yang, S., Delgado, R., King, S. R., et al. (1999) Generation of retroviral vector for clinical studies using transient transfection. Hum. Gene Ther. 10, 123–132.
Weng, N. P. and Hodes, R. J. (2000) The role of telomerase expression and telomere length maintenance in human and mouse. J. Clin. Immunol. 20, 257–267.
Harvey, M., Sands, A. T., Weiss, R. S., et al. (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8, 2457–2467.
Mcleod, K. (1999) pRb and E2F-1 in mouse development and tumorigenesis. Curr. Opin. Genet. Dev. 9, 31–39.
Ponten, J. (1976) The relationship between in vitro transformation and tumor formation in vivo. Biochim. Biophys. Acta 458, 397–422.
Sager, R. (1984) Resistance of human cells to oncogenic transformation. Cancer Cells 2, 487–493.
Hodes, R. J. (1999) Telomere length, aging and somatic cell turnover. J. Exp. Med. 190, 153–156.
Prowse, K. R. and Greider, C. W. (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818–4822.
DePinho, R. A. (2000) The age of cancer. Nature 408, 248–254.
DiLeonardo, A., Linke, S. P., Clarkin, K., and Wahl, G. M. (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540–2551.
Robles, S. J. and Adami, G. R. (1998) Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16, 1113–1123.
Suzuki, K., Mori, I., Nakayama, Y., Miyakoda, M., Kodama, S., and Watanabe, M. (2001) Radiation-induced senescence-like growth arrest requires TP53 function but not telomere shortening. Radiat. Res. 155, 248–253.
Robles, S. J., Buchler, P. W., Negrusz, A., and Adami, G. R. (1999) Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camptothecin. Biochem. Pharmacol. 58, 675–685.
Chang, B. D., Broude, E. V., Dokmanovic, M., et al. (1999) A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59, 3761–3767.
Ogryzko, V. V., Hirai, T. H., Russanova, V. R., Barbie, D. A., and Howard, B. H. (1996) Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16, 5210–5218.
Young, J. I. and Smith, J. R. (2001) DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J. Biol. Chem. 276, 19610–19616.
Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., and Lowe, S. W. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008–3019.
Zhu, J., Woods, D., McMahon, M., and Bishop, J. M. (1998) Senescence of human fibroblasts induced by oncogenic raf. Genes Dev. 12, 2997–3007.
Dimri, G. P., Itahana, K., Acosta, M., and Campisi, J. (2000) Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14/ARF tumor suppressor. Mol. Cell. Biol. 20, 273–285.
Dai, C. Y. and Enders, G. H. (2000) p16 INK4a can initiate and autonomous senescence program. Oncogene 19, 1613–1622.
Uhrbom, L., Nister, M., and Westermark, B. (1997) Induction of senescence in human malignant glioma cells by p16INK4a. Oncogene 15, 505–514.
Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., and Lowe, S. W. (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14, 2015–2027.
Pearson, M., Carbone, R., Sebastiani, C., et al. (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic RAS. Nature 406, 207–210.
Chang, B. D., Watanabe, K., Broude, E. V., et al. (2000) Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc. Natl. Acad. Sci. USA 97, 4291–4296.
Kagawa, S., Fujiwara, T., Kadowaki, Y., et al. (1999) Overexpression of the p21/sdi1 gene induces senescence-like state in human cancer cells: implications for senescence-directed molecular therapy for cancer. Cell Death Differ. 6, 765–772.
Collado, M., Medema, R. H., Garcia-Cao, I., et al. (2000) Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27 Kip1. J. Biol. Chem. 275, 21960–21968.
Wei, S., Wei, S., and Sedivy, J. M. (1999) Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59, 1539–1543.
Campisi, J. (1998) The role of cellular senescence in skin aging. J. Invest. Dermatol. 3, 1–5.
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P., and Campisi, J. (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc. Natl. Acad. Sci. USA 98, 12,072–12,077.
Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., and Smith, H. S. (1996) Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274, 2057–2059.
Jonason, A. S., Kunala, S., Price, G. T., et al. (1996) Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA 93, 14025–14029.
Cha, R. S., Thilly, W. G., and Zarbl, H. (1994) N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc. Natl. Acad. Sci. USA 91, 3749–3753.
Ide, T., Tsuji, Y., Ishibashi, S., and Mitsui, Y. (1983) Reinitiation of host DNA synthesis in senescent human diploid cells by infection with simian virus 40. Exp. Cell Res. 143, 343–349.
Gorman, S. D. and Cristofalo, V. J. (1985) Reinitiation of cellular DNA synthesis in BrdU-selected nondividing senescent WI38 cells by simian virus 40 infection. J. Cell. Physiol. 125, 122–126.
Galloway, D. A. and McDougall, J. K. (1989) Human papillomaviruses and carcinomas. Adv. Virus Res. 37, 125–171.
Shay, J. W., Wright, W. R., and Werbin, H. (1991) Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta 1071, 1–7.
Kierstead, T. D. and Tevethia, M. J. (1993) Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 67, 1817–1829.
Sakamoto, K., Howard, T., Ogryzko, V., et al. (1993) Relative mitogenic activities of wild-type and retinoblastoma binding defective SV40 T antigens in serum deprived and senescent human fibroblasts. Oncogene 8, 1887–1893.
Linskens, M. H. K., Feng, J., Andrews, W. H., et al. (1995) Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res. 23, 3244–3251.
Komarova, E. A., Diatchenko, L., Rokhlin, O. W., et al. (1998) Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene 17, 1089–1096.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Campisi, J. (2003). Analysis of Tumor Suppressor Gene-Induced Senescence. In: El-Deiry, W.S. (eds) Tumor Suppressor Genes. Methods in Molecular Biology™, vol 223. Humana Press. https://doi.org/10.1385/1-59259-329-1:155
Download citation
DOI: https://doi.org/10.1385/1-59259-329-1:155
Publisher Name: Humana Press
Print ISBN: 978-0-89603-987-2
Online ISBN: 978-1-59259-329-3
eBook Packages: Springer Protocols